PML and carcinoma: Further investigation is warranted to determine why this recruitment is impaired in carcinoma cell-types that are responsive to IFN signalling (Fig 3G, S5 Fig), but may reflect changes in PML-NB composition, CDK expression levels, or host chromatin epigenetic status, which are frequently altered upon carcinoma transformation.